MFC Co., Ltd. Logo

MFC Co., Ltd.

A GMP-certified CDMO/CMO for the R&D and production of APIs and intermediates.

432980 | KO

Overview

Corporate Details

ISIN(s):
KR7432980001
LEI:
Country:
South Korea
Address:
경기도 화성시 마도면 청원산단7길 35(청원리 1453), 화성시

Description

MFC Co., Ltd., established in 2008, is a pharmaceutical company specializing as a Contract Development and Manufacturing Organization (CDMO) and Contract Manufacturing Organization (CMO). The company's core activities include the research, development, and production of Active Pharmaceutical Ingredients (APIs) and key intermediates. Its manufacturing processes adhere to Good Manufacturing Practice (GMP) standards, as certified by the Korean Ministry of Food and Drug Safety (KMFDS).

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-02-12 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-02-12 00:00
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 10.6 KB
2025-02-05 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 22.2 KB
2025-01-06 00:00
주식등의대량보유상황보고서(약식)
Korean 58.9 KB
2025-01-03 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.5 KB
2025-01-03 00:00
주식등의대량보유상황보고서(일반)
Korean 105.3 KB
2025-01-03 00:00
주식등의대량보유상황보고서(약식)
Korean 54.8 KB
2025-01-03 00:00
주식등의대량보유상황보고서(약식)
Korean 55.2 KB
2024-12-11 00:00
증권발행실적보고서(합병등)
Korean 42.3 KB
2024-10-22 00:00
투자설명서
Korean 4.1 MB
2024-10-10 00:00
[기재정정]증권신고서(합병)
Korean 4.5 MB
2024-10-04 00:00
[기재정정]증권신고서(합병)
Korean 4.6 MB
2024-09-23 00:00
[기재정정]증권신고서(합병)
Korean 7.8 MB
2024-09-10 00:00
[기재정정]증권신고서(합병)
Korean 5.2 MB
2024-08-30 00:00
증권신고서(합병)
Korean 3.7 MB

Automate Your Workflow. Get a real-time feed of all MFC Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for MFC Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for MFC Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.